Total Payments
$12,444
2022 Payments
$20.97
Companies
26
Transactions
687
Medicare Patients
5,790
Medicare Billing
$546,529
Payment Breakdown by Category
Food & Beverage$12,412 (99.7%)
Education$31.97 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,412 | 682 | 99.7% |
| Education | $31.97 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,020 | 76 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $1,507 | 99 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,093 | 59 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $945.39 | 53 | $0 (2021) |
| Chiesi USA, Inc. | $886.48 | 48 | $0 (2021) |
| Gilead Sciences, Inc. | $827.19 | 36 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $690.14 | 36 | $0 (2021) |
| PFIZER INC. | $631.36 | 63 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $602.29 | 30 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $503.66 | 26 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $20.97 | 1 | Bardy Diagnostics, Inc. ($20.97) |
| 2021 | $749.03 | 38 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($119.09) |
| 2020 | $989.35 | 53 | Amgen Inc. ($178.67) |
| 2019 | $3,519 | 189 | Amgen Inc. ($747.36) |
| 2018 | $3,411 | 167 | Amgen Inc. ($544.50) |
| 2017 | $3,755 | 239 | Janssen Pharmaceuticals, Inc ($537.18) |
All Payment Transactions
687 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/13/2022 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 11/30/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: DIABETES | ||||||
| 11/16/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/09/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/27/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/13/2021 | Chiesi USA, Inc. | KENGREAL (Drug), CLEVIPREX | Food and Beverage | Cash or cash equivalent | $18.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/06/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: DIABETES | ||||||
| 09/21/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.55 | General |
| Category: Cardiovascular | ||||||
| 09/17/2021 | Chiesi USA, Inc. | KENGREAL (Drug), CLEVIPREX | Food and Beverage | Cash or cash equivalent | $15.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/07/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/01/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: DIABETES | ||||||
| 08/31/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/25/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/18/2021 | Chiesi USA, Inc. | KENGREAL (Drug), CLEVIPREX | Food and Beverage | Cash or cash equivalent | $14.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/10/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/20/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.26 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/14/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/06/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: DIABETES | ||||||
| 06/23/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.51 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/16/2021 | Chiesi USA, Inc. | KENGREAL (Drug), CLEVIPREX | Food and Beverage | Cash or cash equivalent | $13.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/02/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/25/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/25/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/18/2021 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Cardiology | ||||||
| 05/11/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.28 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,400 | 2,115 | $568,500 | $135,192 |
| 2022 | 18 | 1,483 | 2,127 | $522,835 | $127,519 |
| 2021 | 21 | 1,513 | 2,292 | $604,708 | $156,661 |
| 2020 | 19 | 1,394 | 1,853 | $536,367 | $127,156 |
Total Patients
5,790
Total Services
8,387
Medicare Billing
$546,529
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 300 | 583 | $212,212 | $63,230 | 29.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 130 | 142 | $125,244 | $27,060 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 123 | $30,381 | $9,532 | 31.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 176 | 177 | $43,896 | $9,472 | 21.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 330 | 728 | $60,424 | $8,777 | 14.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $17,174 | $4,754 | 27.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 16 | 16 | $16,208 | $3,624 | 22.4% |
| 76376 | 3d radiographic procedure | Office | 2023 | 69 | 71 | $23,785 | $1,762 | 7.4% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 36 | 38 | $7,106 | $1,484 | 20.9% |
| 93318 | Ultrasound of heart with probe in esophagus to assess heart pump function | Facility | 2023 | 17 | 17 | $9,707 | $1,451 | 15.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 16 | 16 | $3,296 | $846.24 | 25.7% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 13 | 13 | $5,499 | $749.88 | 13.6% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 26 | 26 | $2,626 | $588.25 | 22.4% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 21 | 21 | $1,911 | $447.51 | 23.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 16 | 16 | $1,584 | $409.60 | 25.9% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 15 | 15 | $1,065 | $238.47 | 22.4% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 19 | 19 | $1,197 | $217.80 | 18.2% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 17 | 17 | $1,054 | $191.40 | 18.2% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 15 | 15 | $2,805 | $154.35 | 5.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 13 | 13 | $1,092 | $152.28 | 13.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 18 | 18 | $234.00 | $50.58 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 284 | 526 | $185,678 | $56,237 | 30.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 112 | 120 | $101,280 | $23,186 | 22.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 207 | 211 | $50,007 | $12,432 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 123 | $29,520 | $8,627 | 29.2% |
About Dr. Andrew Rosenblatt, MD
Dr. Andrew Rosenblatt, MD is a Cardiovascular Disease healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932110012.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Rosenblatt, MD has received a total of $12,444 in payments from pharmaceutical and medical device companies, with $20.97 received in 2022. These payments were reported across 687 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($12,412).
As a Medicare-enrolled provider, Rosenblatt has provided services to 5,790 Medicare beneficiaries, totaling 8,387 services with total Medicare billing of $546,529. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location San Francisco, CA
- Active Since 08/11/2006
- Last Updated 04/20/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1932110012
Products in Payments
- XARELTO (Drug) $1,356
- Repatha (Biological) $1,155
- ELIQUIS (Drug) $1,102
- LifeVest (Device) $945.39
- Corlanor (Drug) $865.59
- BRILINTA (Drug) $690.14
- JARDIANCE (Drug) $557.24
- PRADAXA (Drug) $535.58
- KENGREAL (Drug) $474.65
- PRALUENT (Drug) $415.71
- PRALUENT ALIROCUMAB INJECTION (Biological) $370.57
- OPSUMIT MACITENTAN (Drug) $365.36
- NORTHERA (Drug) $349.55
- CLEVIPREX (Drug) $306.62
- ENTRESTO (Drug) $285.00
- PRALUENT (Biological) $231.72
- LEXISCAN (Drug) $183.71
- ZIO Patch (Device) $163.05
- OPSUMIT (Drug) $159.35
- WATCHMAN (Device) $142.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in San Francisco
Dr. Philip Sager, Md, MD
Cardiovascular Disease — Payments: $851,687
Cardiovascular Disease $851,687
Dr. Melvin Scheinman, M.d, M.D
Cardiovascular Disease — Payments: $315,387
Cardiovascular Disease $315,387
Dr. Henry Hsia, Md, MD
Cardiovascular Disease — Payments: $296,299
Cardiovascular Disease $296,299
Edward Gerstenfeld, Md, MD
Cardiovascular Disease — Payments: $198,638
Cardiovascular Disease $198,638
Dr. Lloyd Klein, Md, MD
Cardiovascular Disease — Payments: $176,194
Cardiovascular Disease $176,194
Robert Gillespie, M.d, M.D
Cardiovascular Disease — Payments: $116,323
Cardiovascular Disease $116,323